top of page
  • Writer's pictureD. Brit

FDA Advisers Recommend J&J Vaccine Receive Emergency Use Authorization

What Happened:

  • On Friday, a panel of vaccine advisers to the FDA recommended that the agency grant emergency use authorization for the Johnson & Johnson Covid-19 vaccine.

  • The FDA's Vaccine and Related Biological Products Advisory Committee voted unanimously in favor of approving the J&J vaccine for emergency use in people 18 or older.

  • The FDA is expected to act on the recommendation quickly. If approved, the Johnson and Johnson vaccine would become the third Covid-19 vaccine in the US to receive emergency use authorization, along with Pfizer and Moderna. The J&J vaccine would also become the first single-dose vaccine authorized to treat the virus.

  • The Johnson & Johnson vaccine was found to be 66.9% effective at preventing moderate to severe Covid-19 symptoms and 85% effective against very serious symptoms. The J&J vaccine was less effective against the mutated South African version of the virus.

  • J&J says they can roll-out 100 million doses by the end of June, if they receive FDA approval.

  • Although less effective than the two-dose Pfizer and Moderna vaccines, J&J's single-dose vaccine could be much easier to roll-out and does not require the same sub-zero refrigeration, facilitating transportation and storage.

Photo Source: Angelo Esslinger

#newspura #justfactsnoopinions #covid19 #coronavirus #vaccine #johnsonandjohnson #oneshotvaccine #news #breaking #breakingnews #emergencyuseauthorization

3 views0 comments
bottom of page